Form 4: Oscar Health's Chief Legal Officer, Adam McAnaney, Reports Acquisition of Restricted Stock Units
SEC Form 4 Filing
Adam McAnaney, Chief Legal Officer of Oscar Health, Inc., reports the acquisition of restricted stock units (RSUs) and updates to his beneficial ownership of Class A Common Stock.
Summary
- Adam McAnaney, the Chief Legal Officer of Oscar Health, Inc., filed a Form 4 to report changes in his beneficial ownership.
- On March 5, 2025, McAnaney acquired 61,409 shares of Class A Common Stock through restricted stock units (RSUs).
- These RSUs will vest quarterly in 12 equal installments starting June 1, 2025, contingent upon his continuous service.
- Following the reported transaction, McAnaney beneficially owns 184,785 shares of Class A Common Stock.
- The transaction was reported on March 7, 2025.
Sentiment
Score: 7
Explanation: The document reflects a routine transaction related to executive compensation, which is generally neutral to positive as it aligns executive interests with company performance.
Positives
- The acquisition of RSUs aligns the executive's interests with the long-term performance of the company.
- The vesting schedule encourages continued service and commitment from the Chief Legal Officer.
Future Outlook
The vesting of the RSUs is contingent upon the reporting person's continuous service, suggesting an expectation of continued employment.
Industry Context
Form 4 filings are a routine part of executive compensation and provide transparency into the holdings of company insiders. This filing indicates standard equity-based compensation practices within the healthcare industry.
Comparison to Industry Standards
- Equity compensation is a common practice among publicly traded companies, including healthcare firms like UnitedHealth Group (UNH), Anthem (ANTM), and Cigna (CI), to incentivize executives.
- The vesting schedule of 12 quarterly installments is a typical structure for RSU grants, aligning with industry norms for retention and performance incentives.
- The size of the RSU grant should be compared to similar grants at peer companies to assess its relative value and impact on executive compensation.
Stakeholder Impact
- Shareholders may view the RSU grant as a positive incentive for the Chief Legal Officer to remain with the company and contribute to its success.
- Employees may see the grant as a sign of the company's commitment to its leadership team.
Key Dates
| Date | Description |
|---|---|
| 03/05/2025 | Date of transaction: Acquisition of restricted stock units. |
| 06/01/2025 | Start date for quarterly vesting of restricted stock units. |
| 03/07/2025 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.